Lee Ainslie’s Q32 Bio QTTB Stock Holding History

Lee Ainslie’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,236	Closed	-$3.8M	–	307
2018 Q3	$3.8M	Sell	9,236 -31,044	-77%	-$10.5M	0.05%	192
2018 Q2	$14.3M	Buy	40,280 +403	+1%	+$144K	0.17%	62
2018 Q1	$12.4M	Buy	+39,877	New	+$13.4M	0.16%	73

Other funds holding QTTB

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lee Ainslie's QTTB Position: Q4 2018 in Review

Lee Ainslie sold out of Q32 Bio (QTTB) in Q4 2018, closing a stake of 9,236 shares — an estimated $3.8M sold.

Lee Ainslie first reported a position in QTTB in Q1 2018 and held it in 3 quarters. The position peaked at $14.3M in Q2 2018. 65 funds tracked by Wall St. Rank hold QTTB as of Q4 2018.

Lee Ainslie reported no remaining Q32 Bio position as of Q4 2018 after selling out during the quarter.
Lee Ainslie sold 9,236 Q32 Bio shares in Q4 2018, an estimated $3.8M.
Lee Ainslie first reported a position in Q32 Bio in Q1 2018 and held it in 3 quarters.
Lee Ainslie's Q32 Bio position peaked at $14.3M in Q2 2018.
65 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2018.

Based on Maverick Capital's 13F filing for Q4 2018, filed 14 Feb 2019.